Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets

Thrombosis and Haemostasis

Volumn 80, Issue 3, 1998, Pages 463-468

  Lévy Toledano, Sylviane ^a   Maclouf, Jacques ^a   Rosa, Jean Philippe ^a   Galle, Carole ^a   Vallès, Géraldine ^b   Nurden, Paquita ^b   Nurden, Alan T ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE RECEPTOR; THROMBOXANE A2 RECEPTOR STIMULATING AGENT;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER;

EID: 0031757535     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615230     Document Type: Article

References (36)

1. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
2. Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978; 52: 453-66.
3. Du X, Ginsberg MH. Integrin αIIbβ3 and platelet function. Thromb Haemostas 1997; 78: 96-100.
4. Mills DCB. ADP receptors on platelets. Thromb Haemost 1996; 76: 835-56.
5. Gachet C, Hechler B, Léon C, Vial C, Leray C, Ohlmann P, Cazenave J-P. Activation of ADP receptors and platelet function. Thromb Haemost 1997; 7:271-5.
6. Léon C, Hechler B, Vial C, Leray C, Cazenave J-P, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Letts 1997; 403: 26-30.
7. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith B, Kunapuli SP. Molecular basis for ADP-induced platelet activation. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
8. Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-4.
9. Cattaneo MB, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-96.
10. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden AT. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Evidence for more than one pathway of GP IIb-IIIa complex activation. J Clin Invest 1995; 95: 1612-22.
11. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave J-P. Purinoreceptors on blood platelets: Further pharmacological and clinical evidence to suggest the presence of two receptors. Br J Haematol 1995; 91. 434-44.
12. Humbert M, Nurden P, Bihour C, Pasquet J-M, Winckler J, Heilmann E, Savi P, Herbert J-M, Kunicki TJ, Nurden AT. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol 1996; 15: 1532-43.
13. Brass LF, Hoxie JA, Manning DR, Signalling through G proteins-coupled receptors during platelet activation. Thromb Haemost 1993; 70: 217-23.
14. Clark EA, Brugge JS. Tyrosine phosphorylation in platelets. Potential roles in intracellular signal transduction. Trends Cardiovasc Med 1993; 3: 218-27.
15. Lévy-Toledano S, Gallet C, Nadal F, Bryckaert M, Maclouf J, Rosa J-P. Phosphorylation and dephosphorylation mechanisms in platelet function: a tightly regulated balance. Thromb Haemost 1997; 78: 226-33.
16. Kovacsovics TJ, Bachelot C, Toker H, Vlahos CJ, Duckworth B, Cantley L, Hartwig JH. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 1995: 270: 11358-66.
17. 1α2 proteins. Biochem J 1995; 312: 775-9.
18. 32P)diphosphate, an agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest 1983; 71: 420-8.
19. 2 receptor subtypes. Circ Res 1997; 80: 551-6.
20. Rosa J-P, Artçanuthurry V, Grelac F, Maclouf J, Caen J-P, Lévy-Toledano S. Reassessment of protein tyrosine phosphorylation in thrombasthenic platelets: Evidence that phosphorylation of cortactin and a 64-kD protein is dependent on thrombin activation and integrin αIIbβ3. Blood 1997; 89: 4385-92.
21. Blanco A, Habib A, Levy-Toledano S, Maclouf J. Involvement of tyrosine kinases in the induction of cydo-oxygenase-2 in human endothelial cells. Biochem J 1995; 312: 419-23.
22. Pasquet J-M, Dachary-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996; 239: 647-54.
23. Golden A, Brugge JS. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci USA 1989; 86: 901-5.
24. Rao AK, Willis J, Holmsen H. A major role of ADP in thromboxane transfer experiments : studies in patients with platelet secretion defects. J Lab Clin Med 1984; 104: 116-26.
25. Mackenzie AB, Mahaut-Smith MP, Sage SO. Activation of receptor-operated channels via P2X1 not P2T purinoreceptors in human platelets. J Biol Chem 1996; 27, 1: 2879-81.
26. Gachet C, Cazenave J-P, Ohlmann P, Hilf G, Wieland T, Jakobs KH. ADP receptor-induced activation of guanine nucleotide-binding proteins in human platelet membranes. Eur J Biochem 1992; 207: 259-63.
27. Gabheta J, Yang X, Kowalska MA, Sun L, Dhanasekaran N, Rao AK. Platelet signal transduction defect with Gα subunit disfunction and diminished Gαq in a patient with abnormal platelet responses. Proc Natl Acad Sci USA 1997; 94: 8750-5.
28. Ferrel JE, Martin GS. Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci USA 1989; 86: 2234-9.
29. Golden A. Brugge JS, Shattil SJ. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J Cell Biol 1990; 111: 3117-25.
30. Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990; 75: 1081-6.
31. Kinlough-Rathbone RL, Reimers HJ, Mustard JF, Packham MA. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science, 1976; 192: 1011-2.
32. 2 can induce platelet aggregation in the absence of secretion. Nature, 1977; 269: 66-9.
33. Savi P, Dol F, Herbert JM. ADP-dependence of platelet activation induced by a thrombin receptor agonist. Nouv Rev Fr Hematol 1993; 35: 115-9.
34. Savi P, Herbert J-M. ADP receptors and ADP-selective antiaggregating agents. Medicinal Research Reviews 1996; 16: 159-79.
35. Savi P, Laplace MC, Herbert JM. Evidence for the existence of two different ADP-binding sites on rat platelets. Thromb Res 1994; 76: 157-69.
36. Savi P, Artçanuthurry V, Bornia J, Grelac F, Maclouf J, Lévy-Toledano S, Herbert JM. Effect of clopidogrel treatment on ADP-induced phosphorylations in rat platelets. Brit J Haematol 1997; 97: 185-91.